SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 197 filers reported holding SEATTLE GENETICS INC in Q1 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,948,000 | -5.3% | 54,846 | -14.1% | 0.01% | -18.2% |
| Q2 2020 | $11,563,000 | +99.4% | 63,825 | +30.6% | 0.01% | +57.1% |
| Q1 2020 | $5,798,000 | -31.7% | 48,854 | -34.3% | 0.01% | +16.7% |
| Q4 2019 | $8,495,000 | +70.1% | 74,343 | +27.1% | 0.01% | +50.0% |
| Q3 2019 | $4,994,000 | +21.5% | 58,482 | -1.5% | 0.00% | +33.3% |
| Q2 2019 | $4,111,000 | -28.6% | 59,389 | -24.5% | 0.00% | -40.0% |
| Q1 2019 | $5,758,000 | +36.1% | 78,616 | +5.3% | 0.01% | +25.0% |
| Q4 2018 | $4,231,000 | -15.1% | 74,668 | +15.5% | 0.00% | 0.0% |
| Q3 2018 | $4,984,000 | +543.1% | 64,640 | +453.3% | 0.00% | +300.0% |
| Q2 2018 | $775,000 | +41.9% | 11,682 | +12.1% | 0.00% | – |
| Q1 2018 | $546,000 | +21.6% | 10,417 | +24.3% | 0.00% | – |
| Q4 2017 | $449,000 | +731.5% | 8,381 | +727.3% | 0.00% | – |
| Q3 2017 | $54,000 | -41.3% | 1,013 | -42.7% | 0.00% | – |
| Q2 2017 | $92,000 | -79.7% | 1,767 | -75.6% | 0.00% | – |
| Q1 2017 | $454,000 | +266.1% | 7,235 | +280.2% | 0.00% | – |
| Q4 2016 | $124,000 | +117.5% | 1,903 | +81.2% | 0.00% | – |
| Q3 2016 | $57,000 | +35.7% | 1,050 | 0.0% | 0.00% | – |
| Q2 2016 | $42,000 | +320.0% | 1,050 | +288.9% | 0.00% | – |
| Q1 2016 | $10,000 | -67.7% | 270 | -60.8% | 0.00% | – |
| Q4 2015 | $31,000 | +121.4% | 688 | +78.7% | 0.00% | – |
| Q3 2015 | $14,000 | -73.6% | 385 | -65.0% | 0.00% | – |
| Q2 2015 | $53,000 | +5200.0% | 1,100 | +4900.0% | 0.00% | – |
| Q1 2015 | $1,000 | -96.9% | 22 | -97.8% | 0.00% | – |
| Q4 2014 | $32,000 | -25.6% | 1,000 | -13.0% | 0.00% | – |
| Q3 2014 | $43,000 | -10.4% | 1,149 | -8.0% | 0.00% | – |
| Q2 2014 | $48,000 | +242.9% | 1,249 | +316.3% | 0.00% | – |
| Q1 2014 | $14,000 | -53.3% | 300 | -60.0% | 0.00% | – |
| Q4 2013 | $30,000 | -97.9% | 750 | -97.7% | 0.00% | -100.0% |
| Q3 2013 | $1,414,000 | +1891.5% | 32,250 | +1333.3% | 0.00% | – |
| Q2 2013 | $71,000 | – | 2,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |